Evidence map›Paper›PMID 38476376›Full record

ReviewFrontiers in cardiovascular medicine2024

Impact of the

Hamas Fouda, Wisam N Ibrahim, Zumin Shi, Fahad Alahmadi, Yousef Almohammadi, Amal Al-Haidose, Atiyeh M Abdallah

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Hamas FoudaDepartment of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Wisam N IbrahimDepartment of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Zumin ShiHuman Nutrition Department, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Fahad AlahmadiPediatric Department, College of Medicine, Taibah University, King Faisal Specialist Hospital, Al-Madinah, Saudi Arabia.
Yousef AlmohammadiPediatric Department, Security Forces Medical Centre, Al-Madinah, Saudi Arabia.
Amal Al-HaidoseDepartment of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Atiyeh M AbdallahDepartment of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Qatar University · QASecurity Forces Hospital · SATaibah University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Many factors contribute to the risk of cardiovascular disease (CVD), an umbrella term for several different heart diseases, including inflammation. Macrophage migration inhibitory factor (MIF) is an important immune modulator that has been shown to be involved in the pathogenesis of different heart diseases, so understanding pathogenic variants of the Methods: The PubMed, Science Direct, and Embase databases were searched from inception to June 2023 for case-control studies of the Results: A total of 9,047 participants (4141 CVD cases and 4906 healthy controls) from 11 relevant studies were included. In the total population, there was no significant association between the Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, PROSPERO (CRD42023441139).

Indexed as

ArabAsiancardiovascular diseaseEuropeanmacrophage migration inhibitory factormeta-analysispolymorphism

Identifiers

PMID38476376
PMCPMC10929265
OpenAlexW4392167176

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.